Active Stocks
Wed Feb 12 2025 15:56:53
  1. Tata Steel share price
  2. 132.25 1.65%
  1. ITC share price
  2. 409.50 -2.14%
  1. Power Grid Corporation Of India share price
  2. 257.30 -1.61%
  1. Tata Motors share price
  2. 684.40 0.99%
  1. Infosys share price
  2. 1,863.75 -0.70%
Business News/Market/Market Stats/    WhiteOak Capital Pharma and Healthcare Fund Direct Growth

WhiteOak Capital Pharma and Healthcare Fund Direct Growth

+
  • Equity
  • Sector - Healthcare
  • Rating N.A.
  • Plan
12.77 -0.05 (-0.37%) NAV as on 12 Feb, 2025
  • 5D
  • 1M
  • 6M
  • 1Y
  • 5Y
  • MAX

Key Metrics

  • AUM (in Cr)282.62
  • CAGR 28.03%
  • Exit Load1.00%
  • Expense ratio0.69%
  • CategoryEquity
  • Min Investment500
  • Min SIP100
  • Launch Date2024-02-06

Morning Star Rating N.A.

Risk
Exceptional
Return

Asset Allocation

Holdings As On - 13 February 2025

  • Name
  • Value (Cr)
  • Holding %
  • Clearing Corporation Of India Ltd
  • 20.19
  • 7.14%
View More

Risk & Volitility

  • Alpha 0.00%
  • Beta 0.00
  • Sharpe Ratio0.00
  • Std Deviation 0.00%
  • Tracking Error 0.00%

About Fund

The primary objective of the Scheme is to provide long-term capital appreciation by investing predominantly in equity and equity related instruments of Pharma and Healthcare companies. However, there can be no assurance that the investment objective of the Scheme will be realized.

 

The WhiteOak Capital Pharma and Healthcare Fund Direct Growth has an AUM of 282.62 crores & has delivered CAGR of 0.00% in the last 5 years. The fund has an exit load of 1.00% and an expense ratio of 0.69%. The minimum investment in WhiteOak Capital Pharma and Healthcare Fund Direct Growth is Rs 500 and the minimum SIP is Rs 100.

 

As per morningstar the risk & return rating of the fund are - & Exceptional respectively.

 

The top holdings of the fund include Sun Pharmaceutical Industries, Clearing Corporation Of India Ltd, Divis Laboratories & Cipla.

 

The major sectors where the fund is invested are Biotechnology & Drugs, Healthcare Facilities, Major Drugs & Medical Equipment & Supplies.

 

Some of the similar funds are ITI Pharma and Healthcare Fund Direct Growth, Kotak Healthcare Fund Direct Growth, Quant Healthcare Fund Direct Growth, WhiteOak Capital Pharma and Healthcare Fund Direct Growth, PGIM India Healthcare Fund Direct Growth. WhiteOak Capital Pharma and Healthcare Fund Direct Growth has a sharpe ratio of 0.00 & a standard deviation of 0.00%.

FAQs about WhiteOak Capital Pharma and Healthcare Fund Direct Growth

According to the morning star rating WhiteOak Capital Pharma and Healthcare Fund Direct Growth has a & Exceptional return.
WhiteOak Capital Pharma and Healthcare Fund Direct Growth is managed by Piyush Baranwal,Ramesh Mantri,Dheeresh Pathak,Naitik Shah.
The expense ratio of WhiteOak Capital Pharma and Healthcare Fund Direct Growth is 0.69%.
The 5 year annualized return on WhiteOak Capital Pharma and Healthcare Fund Direct Growth is 0.00% & it has generated 28.03% in the last 1 year.
The minimum investment in WhiteOak Capital Pharma and Healthcare Fund Direct Growth is 500 Rs.
WhiteOak Capital Pharma and Healthcare Fund Direct Growth has an AUM of 282.62 crores.
Recommended For You